g(m1)-oligosaccharide has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feuerstacke, Y; Götze, KS; Meyer zum Büschenfelde, C; Peschel, C; Scholze, K | 1 |
1 other study(ies) available for g(m1)-oligosaccharide and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
GM1 expression of non-Hodgkin's lymphoma determines susceptibility to rituximab treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, Neoplasm; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Membrane Microdomains; Oligosaccharides; Prognosis; Rituximab | 2008 |